Received: 24 November 2021
Accepted: 11 April 2022
First Online: 4 May 2022
: The design of the study was approved by the ethical committee of the Verona AOUI (protocol number 65121). All patients signed an informed consent before enrolling in the study.
: All patients were enrolled after to a full explanation of our trial and a signed informed consent.
: The authors declare that they have no competing interests.